Epidemiology of pertussis in an urban region of Poland: Time for a booster for adolescents and adults

Advances in Experimental Medicine and Biology

Volumn 755, Issue , 2013, Pages 203-212

  Nitsch Osuch, Aneta ^a   Kuchar, Ernest ^b   Modrzejewska, Grazyna ^c   Pirogowicz, Iwona ^b   Zycinska, Katarzyna ^a   Wardyn, Kazimierz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Department of Epidemiology Local Sanitary Station   (Poland)

Author keywords

Booster; Epidemiology; Infection incidence; Pertussis; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CONFERENCE PAPER; FEMALE; HUMAN; INCIDENCE; INFANT; LENGTH OF STAY; MALE; MASS IMMUNIZATION; PERTUSSIS; POLAND; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; URBAN AREA;

EID: 84867525300     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4546-9_26     Document Type: Conference Paper

References (44)

1. ACIP. (2006). Recommendations of the advisory committee on immunization practices and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Morbidity and Mortality Weekly Report, 55, 1-33.
2. Bisgard, K. M., Pascual, F. B., Ehresmann, K. R., Miller, C. A., Cianfrini, C., Jennings, C. E., Rebmann, C. A., Gabel, J., Schauer, S. L., & Lett, S. M. (2004). Infant pertussis: Who was the source? Pediatric Infectious Disease, 23, 985-989.
3. Blandiardi, F., & Ferrera, G. (2009). Reducing the risk of pertussis in newborn infants. American Journal of Preventive Medicine, 50, 206-216.
4. CDC (Centres for Disease Control and Prevention). (2005). QuickStats: Rate of hospitalizations for pertussis among infants aged <6 months-United States, 1994-1998 and 1999-2003. Morbidity and Mortality Weekly Report, 54, 1027.
5. Cherry, J. D. (2005). The epidemiology of pertussis: A comparison of the epidemiology of Bordetella pertussis infection. Pediatrics, 115, 1422-1427.
6. Cherry, J. D. (2006). Epidemiology of pertussis. Pediatric Infectious Disease, 25, 351-362.
7. Cherry, J. D. (2010). The present and future of control of pertussis. Clinical Infectious Diseases, 51, 663-667.
8. Committee on Infectious Diseases. (2006). Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics, 117, 965-978.
9. Crowcroft, N. S., Booy, R., Harrison, T., Spicer, L., Britto, J., Mok, Q., Heath, P., Murdoch, I., Zambon, M., George, R., & Miller, E. (2003). Severe and unrecognized: Pertussis in UK infants. Archives of Disease in Childhood, 88, 802-806.
10. de Greeff, S. C., Mooi, F. R., Schellekens, J. F., & de Melker, H. E. (2008). Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. The Pediatric Infectious Disease Journal, 27, 218-223.
11. de Melker, H. E., Schellekens, J. F., Neppelenbroek, S. E., Mooi, F. R., Rumke, H. C., & Conyn-van Spaendonck, M. A. (2000). Re-emergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerging Infectious Diseases, 6, 348-357.
12. EUVAC NET data. www.euvac.net/graphics/euvac/pdf/pertussis . Accessed 22 Apr 2011.
13. Galanis, E., King, A. S., Varughese, P., & Halperin, S. A. (2006). IMPACT investigations. Changing epidemiology and emerging risk groups for pertussis. Canadian Medical Association Journal, 174, 451-452.
14. Gurtis, D., Strebel, P. M., Bardenheier, B., Brennan, M., Tachdjian, R., Finch, E., Wharton, M., & Livengood, J. R. (1999). Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clinical Infectious Diseases, 28, 1230-1237.
15. Halasa, N. B., Barr, F. E., Johnson, J. E., & Edwards, K. M. (2003). Fatal pulmonary hypertension associated with pertussis in infants: Does extracorporeal membrane oxygenation have a role? Pediatrics, 112, 1274-1278.
16. He, Q., & Mertsola, J. (2008). Factors contributing to pertussis resurgence. Future Microbiology, 3, 329-339.
17. Hellenbrand, W., Beier, D., Jensen, E., Littmann, M., Meyer, C., Oppermann, H., Wirsing von Konig, C. H., & Reiter, S. (2009). The epidemiology of pertussis in Germany: Past and present. BMC Infectious Diseases, 9, 22-26.
18. Hewlett, E. L., & Edwards, K. M. (2005). Pertussis-Not just for kids. The New England Journal of Medicine, 352, 1215-1222.
19. Kowalzik, F., Barbosa, A. P., Fernandes, V. R., Carvalho, P. R., Avila-Aguero, M. L., Goh, D. Y., Goh, A., de Miguel, J. G., Moraga, F., Roca, J., Campins, M., Huang, M., Quian, J., Riley, N., Beck, D., & Verstraeten, T. (2007). Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatric Infectious Disease, 26, 238-242.
20. Lasserre, A., Laurent, E., Turbelin, C., Hanslik, T., Blanchon, T., & Guiso, N. (2011). Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area France May 2008 to March 2009. Eurosurveillance, 16, pii: 19783.
21. Mertens, P. L., Stals, F. S., Schellekens, J. F., Houben, A. W., & Huisman, J. (1999). An epidemic of pertussis among elderly people in religious institution in The Netherlands. European Journal of Clinical Microbiology & Infectious Diseases, 18, 242-247.
22. Mooi, F. R. (2010). Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution, 10, 36-49.
23. Mooi, F. R., van Loo, I. H., van Gent, M., He, Q., Bart, M. J., Heuvelman, K. J., de Greeff, S. C., Diavatopoulos, D., Teunis, P., Nagelkerke, N., & Mertsola, J. (2009). Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases, 15, 1206-1213.
24. National Institute of Public Health. (2005). Infectious diseases and poisonings in Poland. Annual Report Year 2005.
25. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/ epimeld/2005/Ch-2005 . Accessed 25 Apr 2011.
26. National Institute of Public Health. (2006). Infectious diseases and poisonings in Poland. Annual Report Year 2006.
27. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/ epimeld/2006/Ch-2006 . Accessed 25 Apr 2011.
28. National Institute of Public Health. (2007). Infectious diseases and poisonings in Poland. Annual Report Year 2007.
29. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/ epimeld/2007/Ch-2007 . Accessed 25 Apr 2011.
30. National Institute of Public Health. (2008). Infectious diseases and poisonings in Poland in 2008.
31. Annual Report. National Institute of Public Health. http://www.pzh.gov. pl/oldpage/epimeld/2008/Ch-2008 . Accessed 25 Apr 2011.
32. National Institute of Public Health. (2009). Infectious diseases and poisonings in Poland in 2009. Annual Report Year 2005.
33. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/ epimeld/2009/Ch-2009 . Accessed 25 Apr 2011.
34. Ntezayabo, B., De Serres, G., & Duval, B. (2003). Pertussis resurgence in Canada largely caused by a cohort effect. Pediatric Infectious Disease Journal, 22, 22-27.
35. Paradowska-Stankiewicz, I., & Rudowska, J. (2010). Pertussis in Poland in 2008. Przegland Epidemiologiczny, 64, 181-183.
36. Parkins, M. D., McNeil, S. A., & Laupland, K. B. (2009). Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention. Canadian Journal of Infectious Diseases & Medical Microbiology, 20, 81-90.
37. Quinn, H. E., & McIntyre, P. B. (2007). Pertussis epidemiology in Australia over the decade 1995-2005-Trends by region and age group. Communicable Diseases Intelligence, 31, 205-215.
38. Rohani, P., Zhong, X., & King, A. A. (2010). Contact network structure explains the changing epidemiology of pertussis. Science, 12, 982-985.
39. Serres, G., Shadmani, R., Duval, B., Boulianne, N., Dery, P., Douville Fradet, M., Rochette, L., & Halperin, S. A. (2000). Morbidity of pertussis in adolescents and adults. Journal of Infectious Diseases, 181, 174-179.
40. Tan, T., Trindade, E., & Skowronski, D. (2005). Epidemiology of pertussis. Pediatric Infectious Disease Journal, 24, S10-S18.
41. Tanaka, M., Vitek, C. R., Pascual, F. B., Bisgard, K. M., Tate, J. E., & Murphy, T. V. (2003). Trends in pertussis among infants in the United States, 1980-1999. Journal of the American Medical Association, 290, 2968-2975.
42. Wendelboe, A. M., Njamkepo, E., Bourillon, A., Floret, D. D., Gaudelus, J., Gerber, M., Grimprel, E., Greenberg, D., Halperin, S., Liese, J., Munoz-Rivas, F., Teyssou, R., Guiso, N., & Van Rie, A. (2007). Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease, 26, 293-299.
43. WHO position paper. (2010). Pertussis vaccines. Weekly Epidemiological Record, 2010 (40), 385-399.
44. Wiese-Posselt, M., & Hellenbrand, W. (2010). Changes to the varicella and pertussis immunisation schedule in Germany 2009 background, rationale and implementation. Eurosurveillance, 15, pii: 19548.